PLAT and stroke disorder: We have shown that Vepoloxamer treatment reduces microvascular thrombosis via blocking stroke provoked platelet aggregation and activation in adult rats and that Vepoloxamer extends the tPA therapeutic window by enhancing thrombolysis and reducing tPA induced cerebrovascular disruption (21).